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Abstract 12 
The arrival and discharge of seven antibiotics were monitored at two trickling filter sewage 13 
treatment plants of 6,000 and 11,000 population equivalents (PE) and two activated sludge plants 14 
of 33,000 and 162,000 PE in Southern England.  The investigation consisted of 24 h composite 15 
samples taken on two separate days every summer from 2012 to 2015 and in the winter of 2015 16 
(January) from influent and effluent.  The average influent concentrations generally matched 17 
predictions based on England-wide prescription data for trimethoprim, sulfamethoxazole, 18 
azithromycin, oxytetracycline and levofloxacin (within 3-fold), but were 3-10 times less for 19 
clarithromycin, whilst tetracycline influent concentrations were 5-17 times greater than expected.  20 
Over the four years, effluent concentrations at a single sewage plant varied by up to 16-fold for 21 
clarithromycin, 10-fold for levofloxacin and sulfamethoxazole, 7-fold for oxytetracycline, 6-fold for 22 
tetracycline, 4-fold for azithromycin and 3-fold for trimethoprim.  The study attempted to identify 23 
the principal reasons for this variation in effluent concentration.  By measuring carbamazepine and 24 
using it as a conservative indicator of transport through the treatment process, it was found that 25 
flow and hence concentration could alter by up to 5-fold.  Measuring influent and effluent 26 
concentrations allowed assessments to be made of removal efficiency.  In the two activated sludge 27 
plants, antibiotic removal rates were similar for the tested antibiotics but could vary by several-fold 28 
at the trickling filter plants.  However, for clarithromycin and levofloxacin the variations in effluent 29 
concentration were above that which could be explained by either flow and/or removal alone so 30 
here year on year changes in consumption are likely to have played a role. 31 
. 32 
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Highlights 33 
 Concentrations of 7 antibiotics were measured in 4 sewage treatment plants (STPs) 34 
 Prescription data was used to predict concentrations in influent and effluent 35 
 Measured concentrations and removal rates in STPs were very variable 36 
 Average measured values were in line with predictions for 5 of 7 antibiotics 37 
 Changes in flow, removal rates and consumption influenced effluent levels 38 
Capsule 39 
Considerable variation in effluent concentration for 7 antibiotics in 4 sewage treatment plants over 40 
4 years was observed.  This variation was driven by changes in wastewater flow, removal rates and 41 
local drug consumption 42 
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Abbreviations 51 
TRIM – trimethoprim, SMX – sulfamethoxazole, CBZ – Carbamazepine, CLAR – clarithromycin, AZO – 52 
azithromycin, TET – tetracycline, OXY – oxytetracycline, LEVO – levofloxacin, STP – sewage treatment plant, 53 
AS – activated sludge, TF – trickling filter 54 
 55 
1.  Introduction 56 
Prioritisation exercises for pharmaceuticals in the environment typically list antibiotics as 57 
one of the groups of highest concern (Besse and Garric, 2008; Christensen et al., 2009; Cooper et 58 
al., 2008).  Their high ranking is linked not only to their high levels of consumption and toxicity to 59 
aquatic wildlife but also to concerns over possible links to antibiotic resistance which could have 60 
consequences for mankind (Ågerstrand et al., 2015).  This was prompted by the co-occurrence of 61 
antibiotics and antibiotic resistance genes in some river environments (Amos et al., 2015; Huerta et 62 
al., 2013; Marti et al., 2013; Marti et al., 2014; Rodriguez-Mozaz et al., 2015).  Geographic based 63 
modelling has been used as part of the risk assessment process for antibiotics (Johnson et al., 2015; 64 
Singer et al., 2014).  If we should wish to remove more antibiotics in sewage treatment, it will be 65 
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important to identify the factors associated with good performance.  Currently this is difficult due 66 
to the surprisingly wide variety in effluent concentrations and apparent removal rates of similar 67 
antibiotics found in the literature.   68 
There have been a number of studies which have examined temporal changes in antibiotic 69 
loadings in sewage treatment plants (STPs) ranging from daily (Coutu et al., 2013; Singer et al., 70 
2014) to seasonal (Gracia-Lor et al., 2012).  Probably the most notable observation has been a 71 
seasonal increase in consumption for some antibiotics associated with winter.  For example, in the 72 
Czech Republic and Switzerland, both clarithromycin and trimethoprim consumption doubled in 73 
winter (Coutu et al., 2013; Golovko et al., 2014; McArdell et al., 2003).  For sulfamethoxazole, 74 
concentrations in influent rose by one-quarter to one-third in winter in the Czech Republic, Greece 75 
and China (Golovko et al., 2014; Kosma et al., 2014; Zhang et al., 2015), but in Portugal 76 
consumption was higher in spring than summer for the two antibiotics studied (azithromycin and 77 
ciprofloxacin) (Pereira et al., 2015).  Sometimes the observed loadings (consumption) appear to be 78 
a lot higher than might have been expected from reviewing national or regional prescription data 79 
(Singer et al., 2014).   80 
There have not been many studies reviewing the performance of different sewage 81 
treatment types with respect to antibiotics, but in a Chinese study a membrane bioreactor gave 82 
better removal performance for trimethoprim than a conventional activated sludge (AS) plant (Sui 83 
et al., 2011).  In the UK there did not appear to be a consistent trend in performance between 84 
activated sludge plants or trickling filters with respect to oxytetracycline removal (Gardner et al., 85 
2013).   86 
Regarding seasonal changes in sewage treatment removal performance, for the Czech 87 
Republic it appeared that clarithromycin and trimethoprim removal improved by 20% in summer 88 
compared to winter, whilst levofloxacin and sulfamethoxazole improved by 10% (Golovko et al., 89 
2014).  In a Chinese study, trimethoprim removal performance improved from 30 to 80% in the 90 
Beijing summer, which might have been temperature related (Sui et al., 2011).  In Portugal, higher 91 
azithromycin and ciprofloxacin removal was reported in summer compared to spring (80% versus 92 
50%).   93 
These studies imply consumption for some antibiotics could increase between two and four-94 
fold in winter and removal performance decline by more than 2/3.  However, this may not always 95 
lead to higher antibiotic concentrations in the river.  Many Western countries experience their 96 
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highest river flows in winter, so that dilution might rise 30-fold (Johnson, 2010) which more than 97 
compensates for relatively minor changes in seasonal antibiotic use or removal efficiency. 98 
Changes in effluent concentrations of antibiotics over several years at the same STP has not 99 
been examined before.  Nor have there been serious attempts to disentangle the reasons for 100 
variations in effluent concentrations over long time-scales.  A better understanding of why there 101 
are differences in antibiotic discharge between STPs would assist both risk assessment and a 102 
strategy to improve their removal from wastewater. 103 
Following the development of a method, which permitted the simultaneous analysis of 104 
several pharmaceuticals in wastewater including some key antibiotics, a study was prepared to look 105 
at several antibiotics in use in the UK.  Sulfamethoxazole (SMX) is used to treat infections such as 106 
urinary tract, inner ear, prostitis and bronchitis.  It is one of the sulphonamide group which entered 107 
the market in the 1970s and inhibits an enzyme involved in the synthesis of tetrahydrafolic acid 108 
(part of the thymidine metabolic pathway in DNA synthesis) (Seydel et al., 1972).  Trimethoprim 109 
(TRIM) is used to treat a number of infections including those of the urinary and respiratory tract 110 
and belongs to the class of chemotherapeutic agents known as dihydrofolate reductase inhibitors.  111 
TRIM acts by targeting an enzyme involved in the tetrahydrafolic acid pathway and so SMX and 112 
TRIM have often been used together in therapy since the late 1960s (Burchall, 1973; Seydel et al., 113 
1972).  Clarithromycin (CLAR) is used to treat infections such as skin, throat and pneumonia.  114 
Azithromycin (AZO) has been used to treat throat, intestinal and sexually transmitted infections.  115 
Both of these are macrolide antibiotics which came on the market in the early 1990s and bind to 116 
the microbial 50s ribosome sub-unit thereby inhibiting protein synthesis (Piscitelli et al., 1992; 117 
Retsema et al., 1987).  Tetracycline (TET) is often used in treating skin infections and Lyme disease 118 
whilst oxytetracycline (OXY) has been used to treat skin, chest and genital infections.  These two 119 
antibiotics have been in use since the 1960s and target the microbial 30s ribosomal sub-unit to 120 
inhibit protein synthesis (Gale, 1963).  Levofloxacin (LEVO) has been used to treat a range of 121 
infections including intestinal, pneumonia, urinary tract and prostitis.  It belongs to the 122 
fluoroquinolone group of antibiotics, which became widely used from 1990, and function by 123 
inhibiting the DNA gyrase and topoisomerase IV enzymes (Drlica and Zhao, 1997; Hooper et al., 124 
1987). 125 
By looking at 4 different sewage treatment plants over 4 years, sampling on two occasions each 126 
year through taking 24 h composite samples, this study attempted to address the following 127 
questions: 128 
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How variable are antibiotic effluent concentrations over four years within four different UK 129 
sewage treatment plants?  To what extent are antibiotic influent and effluent concentrations 130 
predictable based on National consumption rates? To what extent does sewage treatment type 131 
influence removal performance? How important are flow, removal performance or changes in 132 
drug consumption in the variability of antibiotic effluent concentrations? 133 
 134 
2.  Materials and methods 135 
2.1.  Sampling approach at the treatment plants and flow assessment 136 
Four separate STPs in Southern England, UK were examined (Table 1).  Two plants were of 137 
the activated sludge (AS) type (Ox and Did) and two smaller plants of the trickling filter (TF) type 138 
(Ben and Cho).  In the UK, AS plants have a hydraulic residence time in the region of 10-14 h and TF 139 
plants only 0.5 h.  The AS plants handle the most wastewater but TFs are the most numerous 140 
(Johnson et al., 2007).  A 24 hr composite sample was collected by combining hourly samples using 141 
an autosampler (Isco Avalanche, Isco 6712, Hach Sigma SD 900 or Bühler Montec Xian 1000).  Each 142 
treatment plant was sampled, using composite samplers, on two separate occasions during each 143 
sampling campaign in June 2012, August 2013, August 2014 and January and August 2015.  There 144 
have been issues with insufficient or inappropriate sample frequency leading to a number of 145 
misinterpretations in understanding the fate of pharmaceuticals in treatment plants (Ort et al., 146 
2010).  One example is that in periods of high rainfall both rainwater and elevated groundwater can 147 
enter the sewer system, which could have the effect of greatly diluting concentrations of chemicals 148 
derived from local households.  However, these sampling periods did not occur during periods of 149 
high rainfall in the region (Table S1).  In addition, this study used carbamazepine as a form of 150 
conservative tracer to help avoid misinterpretations of the relative influence of flow versus other 151 
losses as described further below. 152 
 153 
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Table 1 Sewage treatment plants sampled in the survey 154 
Type Tertiary 
treatment 
Name Human 
PE (k) 
Ave.  dry weather 
flow (m3/d) 
L/person 
AS None Ox 162.8 38,000 233 
AS Sand filter Did 31.7 8,000 252 
TF Particle filter Cho 11.3 2,406 213 
TF 
Nitrifying Fixed 
bed bioreactor 
& Particle filter 
Ben 5.9 1,368 232 
 155 
AS Activated Sludge  156 
TF Biological filter (trickling filter)  157 
Human PE  human population equivalent = head of population connected to the sewage plant 158 
Values from the database for the LF2000WQX model (Williams et al., 2009) 159 
 160 
 Unfortunately, daily flow values at the STPs were not available, only the consented flow 161 
(Table 1).  In the UK, sewage treatment is managed by private companies and there is no 162 
requirement to make such information publically available.  However, the conservative 163 
pharmaceutical carbamazepine (CBZ) makes a very suitable indicator for changes in flow.  It is very 164 
widely prescribed for epilepsy patients, who take this medication at the same dose throughout the 165 
year, and its remarkable persistence has been noted before (Clara et al., 2004; Nakada et al., 2008).  166 
Measurements taken in this study showed no decline between the influent and effluent (Tables S4 167 
and S6). 168 
 169 
2.2 Analytical approach 170 
The method of pharmaceutical analysis described elsewhere (Narumiya et al., 2013) was 171 
used with minor modifications.  Briefly, water samples were taken in polyethylene bottles or 172 
buckets, to which 1 g/L ascorbic acid had been added as a preservative.  Immediately after being 173 
taken, the samples were filtered through glass fibre filters (GF/B, 1.0 μm, Whatman, UK) and EDTA 174 
(to be approximately 1 g/L) and a 50 µL of surrogate mixture (1 mg/L of each isotope-labelled 175 
pharmaceutical dissolved in methanol) were added into the filtrate. The antibiotics were 176 
concentrated by solid-phase extraction in an OASIS HLB cartridge (200 mg, 6 cm3, Waters, MA) 177 
within 1 d after sampling.  The cartridges were kept at 4 °C in darkness and transported to Kyoto 178 
University, Japan, where the compounds retained in the cartridge were eluted with 6mL of 179 
methanol after being dried for 1 h under gentle air pressure in a glass manifold.  The eluents were 180 
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dried with nitrogen gas and dissolved in 1 mL of 0.1% formic acid and methanol (85:15, v/v).  The 181 
antibiotics were measured by ultra-performance liquid chromatography–tandem mass 182 
spectrometry (LC–MS/MS) and the values quantified were correlated with the recovery rate of the 183 
surrogate (Narumiya et al., 2013).  Antibiotic concentrations were reported after a three-tiered 184 
assessment (Kuroda et al., 2015) as follows.  First, the concentration in the sample in the injection 185 
vial had to be more than three times higher than that in the running blank for each sampling day; 186 
otherwise, the concentration was reported as below the limit of quantification (<LOQ).  Second, the 187 
signal to noise ratio (S/N) had to be more than 10; otherwise, the concentration was also reported 188 
as <LOQ.  Finally, the recovery of surrogate compounds had to be more than 30%; otherwise, the 189 
concentration was reported as LR (low recovery).  For running blank samples, 100 - 500 mL of 190 
ultrapure water (Milli-Q waters) was analysed in each week during the sampling period.  The LOQ 191 
was set at the larger value of either three times of the running blank concentration or the sample 192 
concentration with a signal to noise ratio of 10. 193 
 194 
2.3 Predicting antibiotic per capita consumption, influent and effluent concentrations 195 
 196 
It is possible to access English data on prescriptions from the Health and Social Care 197 
Information website for pharmaceutical consumption 198 
http://www.hscic.gov.uk/searchcatalogue?productid=17711.  In theory, this data should be a 199 
reasonable guide, since in the UK antibiotics are only obtained by prescription from a medical 200 
practice.  This can be used to calculate per capita consumption using the population data for that 201 
year obtained from the Office for National statistics http://www.ons.gov.uk/ons/rel/pop-202 
estimate/population-estimates-for-uk--england-and-wales--scotland-and-northern-ireland/2013/index.html 203 
To predict influent concentrations, the amount of intact parent compound excreted by patients 204 
needs to be found from the medical literature.  This will have some limitations as it is not always 205 
clear whether a study refers to a conjugated or free compound, and faecal excretion is often not 206 
reported.  In this study a mean as well as highest and lowest excretion value was recorded (Table 207 
S2).  From this, a probable influent concentration range can be predicted using the mean 208 
wastewater discharge per capita of 233 L/d for these STPs (Table 1).  Removal rates for sewage 209 
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treatment can also be compiled from the literature and are reported as a weighted mean, highest 210 
and lowest removal (Table S3).   211 
To summarise, the influent concentrations are predicted by taking the drug consumption per capita 212 
for a nation less that prevented from being excreted as the free parent compound.  For the effluent 213 
concentration the value is modified by that removed in sewage treatment.  So, for example, the 214 
effluent concentration (W, in ng/L) is derived as follows: 215 
W=
(C x E x (1−R)
D
 216 
Where C is the substance consumption (ng/cap/d); E is the substance amount not excreted 217 
(ng/cap/d); R is the amount of the drug that is prevented from escaping into sewage effluent 218 
(ng/cap/d); and D is the volume of wastewater ( L/cap/d). 219 
The mean excretion and mean sewage removal rate can be combined to report the 220 
expected effluent concentration, whilst the lowest excretion rate and highest sewage removal rate 221 
predict the best possible effluent concentration and finally, the highest excretion rate and lowest 222 
sewage removal rate predict the worst possible effluent concentration.   223 
 224 
3.  Results and discussion 225 
 226 
 In this discussion of the results, it is important to distinguish between observations of 227 
effluent concentration, which is about exposure, and an explanation of the factors which might be 228 
driving that variation in effluent concentration.  Recording the differences in effluent concentration 229 
has a value in its own right since it is important to assess and predict environmental exposure as 230 
accurately as we can.  Exposure models need corroboration with measured data.  Then there is the 231 
issue of trying to identify the principal cause behind that variability.  There are three major 232 
candidates to explain the variability in effluent exposure, these are; that changes in flow (dilution) 233 
is the driving variable in the STP, that the quantity of drugs arriving at the STP is changing (human 234 
consumption), or that removal within the STP is fluctuating.  As tools to examine why there are 235 
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differences in effluent concentration, we can compare with the influent concentration (to give an 236 
indication of removal) and with a conservative indicator to tell us about changes in flow. 237 
Carbamazepine (CBZ) is a suitable conservative indicator, because the molecule is very resistant to 238 
degradation and as an epilepsy drug it is consumed at constant rates throughout the year (Clara et 239 
al., 2004; Nakada et al., 2008). 240 
 241 
3.1 Comparison of measured antibiotic concentrations with those predicted by national 242 
consumption 243 
 244 
A fundamental part of predicting antibiotic concentrations in sewage is the use of national 245 
consumption statistics followed by an assessment of patient excretion.  In this study, this approach 246 
gave acceptable predictions for most antibiotics (Table 2).  However, assuming the excretion values 247 
were not erroneous (Table S2), this region appears to consume significantly less CLAR and more TET 248 
than expected for England as a whole.249 
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Table 2.  Consumption, predicted influent and effluent concentrations of the selected antibiotics together with measured influent and effluent 
concentrations.  Numbers in parentheses are highest and lowest expected, or highest and lowest measured. 
 TRIM SMX  CLAR  AZO TET  OXY  LEVO  
Influent         
2014 National use (kg/yr) 11,599 2,255 18,796 2,579 903 16,473 116 
Individual (mg/cap/d) 0.590 0.115 0.955 0.131 0.046 0.837 0.006 
Expected (ng/L)a 1163 (1087-1517) 89 (49-148) 2049 (1517-2459) 225 (67-264) 118 (128-138) 1796 (1078-2515) 21 (17-24) 
Measured Ox (ng/L) 733 (574-1022) 230 (128-356) 533 (247-773) 368 (214-507) 1660c 827c 28 (<LOQ-56) 
Measured Did (ng/L) 575 (313-939) 138 (29-244) 454 (331-579) 207 (77-292) 1887 (747-3028) 1099 (598-1600) 22 (<LOQ-79) 
Measured Cho (ng/L) 588 (202-1582) 163 (62-318) 421 (123-641) 222 (105-359) 1166 (845-1486) 492 (112-872) 1.8d (<LOQ 11) 
Measured Ben (ng/L) 327 (88-529) 32 (11-53) 184 (<LOQ-497) 150 (108-213) 564c 1406c 40 (<LOQ -119) 
Comment on influents 1.6-3.6 x less than 
expected ≈as 
expected 
≈as expected 3.8-11 x less than 
expected, perhaps 
due to low 
consumption 
≈as expected 4.8-16x more 
than expected 
1.3-3.6 x less than 
expected ≈as 
expected 
≈as expected 
Effluent        
Expected (ng/L)b 885 (338-1504) 46 (12-147) 1517 (136-2435) 164 (30-264) 54 (1.2-131) 395 (97-1886) 11 (4.3-18) 
Measured Ox (ng/L) 359 (294-455) 88 (59-141) 98 (24-377) 156 (69-264) 45 (25-84) 32 (17-40) 5.3 (<LOQ-16) 
Measured Did (ng/L) 243 (160-305) 92 (24-140) 104 (40-221) 110 (74-215) 119 (77-173) 84 (43-144) 5.9 (<LOQ-11) 
Measured Cho (ng/L) 208 (128-321) 128 (61-227) 181 (92-338) 91 (48-135) 98 (58-174) 56 (21-146) 2.1 (<LOQ-4.5) 
Measured Ben (ng/L) 161 (87-254) 27 (<LOQ-55) 152 (64-334) 76 (35-133) 133 (42-239) 191 (99-602) 11 (<LOQ-47) 
Comment on effluents 2.5-5.5 x less than 
expected, mainly due 
to low influent conc. 
Variable, but ≈as 
expected 
8.4-16 x less than 
expected mainly due 
to low influent conc. 
≈as predicted Variation 
between STPs 
but closer to 
expectation than 
influent  
Less than 
expected, high 
variation between 
STPs  
≈as expected 
a Calculated with local wastewater discharge of 233 L/cap/d and range of excretion proportions [weighted average (min-max)] given in table S1 
b Calculated with STP removal rates given in table S2: expected value=average excretion with average removal, range=best case (lowest excretion with highest removal) to 
worst case (highest excretion with lowest removal)l 
c Only one valid measurement 
d Very uncertain average, because 5 of 6 values were <LOQ (set to 0 for the calculation) 
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3.2 Variation in carbamazepine concentrations and the relationship to STP flow 250 
 In the absence of metered flow values for the STPs, changes in CBZ concentration were used 251 
as an indicative marker of changes of flow within the sewage treatment system.  To serve as a 252 
useful conservative marker it should be readily detectable at all the plants at similar concentrations 253 
proportional to the human population.  This also assumes that a high proportion of the population 254 
consistently consumes and excretes the drug.  In fact, the measurements were broadly similar at all 255 
sites with an influent summer average of 613 ng/L of CBZ.  The compound also did demonstrate a 256 
conservative nature as the effluent concentration was between 94 and 144% of the influent 257 
concentration across the different STPs over the 4 years.  The variation over all years sampled in the 258 
influent CBZ concentration was 2-3 fold at Ox and Ben with 4-fold at Did and 5-fold at Cho.  Thus, 259 
up to a 5-fold variation in influent antibiotic concentration over all years sampled at a STP could be 260 
considered ‘natural’ and potentially linked to flow.  It was noticeable that the January CBZ 261 
concentration was half that of the summer average.  This would be consistent with a doubling of 262 
sewer flow associated with an ingress of rain or groundwater into the system in winter. 263 
 264 
3.3  Variation in antibiotic influent and effluent concentrations 265 
Measurements in the influent proved somewhat challenging with some recovery problems 266 
in this matrix (Table S4), thus the averages shown in figure  1 are sometimes from a smaller number 267 
of successful measurements.  Typically, influent concentrations for these different antibiotics can 268 
double (or halve) depending on the year (Table S5) but the differences can be quite large for some, 269 
such as 8-fold for OXY and TRIM at Cho compared to only 5-fold for CBZ at this plant.  Similarly, an 270 
8-fold variation in influent concentrations of SMX were observed at Did over 3 years compared to a 271 
4-fold variation in CBZ.  This compares with a 3-5-fold seasonal variation in antibiotic loading over 272 
the course of one year at a Swiss STP (Coutu et al., 2013).   273 
 274 
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 275 
Figure 1.  Antibiotic and carbamazepine influent concentrations (mean and SD) at the different plants over 276 
four years.  Note for each STP the number of available influent values were for TRIM n=6-10, for SMX n=7-277 
10, for CLAR n=5-7, for AZO n=4-6, for TET n=1-2, for OXY n=1-2, for LEVO n=1-5 and for CBZ n=5-10 (full 278 
details in Table S4). 279 
 280 
It was planned to take two separate composite samples for both influent and effluent at 281 
each STP a few days apart.  However, autosamplers failed on some occasions whilst on others the 282 
recovery was too low (less than 30%) and so the measurement was not included.  The biggest 283 
problems with recovery were for TET and OXY.  But, for most years, at each location, the results 284 
were from two measurements taken on separate days (Table S4). 285 
Over the four years of sampling, effluent concentrations at an STP could vary by up to 16-286 
fold for CLAR, 10-fold for SMX and LEVO, 7-fold for OXY, 6-fold for TET, 4-fold for AZO and 3-fold for 287 
TRIM (Table S5).  In comparison the effluent concentration of the conservative pharmaceutical CBZ 288 
varied by no more than 4-fold at any STP (Table S5).  For most antibiotics the highest relative 289 
variability in effluent concentrations were found at the smallest works, the trickling filter plant at 290 
Ben (6000 PE) (Fig.  2).   291 
 292 
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 293 
Figure 2.  Antibiotic and carbamazepine effluent concentrations (mean and SD) at the different plants over 294 
four years.  Note for each STP the number of available effluent values were for TRIM n=6-10, for SMX n=5-9, 295 
for CLAR n=5-10, for AZO n=5-9, for TET n=3-8, for OXY n=3-8, for LEVO n=3-6 and for CBZ n=5-10 (full details 296 
in Table S4). 297 
  298 
3.4 The role played by changes in STP flow on antibiotic concentrations 299 
 300 
 The anti-epileptic pharmaceutical CBZ was selected as a conservative indicator and thus 301 
reveal the impact of changes in wastewater flow entering the treatment plants.  Thus, an increase 302 
in CBZ concentration was interpreted as a reduction in the quantity of wastewater in the sewer (i.e. 303 
reduced dilution) whilst a big reduction of CBZ concentration would most likely reflect an ingress of 304 
rain or groundwater causing dilution in the system.  As an example, for the biggest STP, Ox, it will 305 
be noted that a 26% drop in CBZ concentration which occurred in January 2015 was mirrored by 306 
most antibiotics where we have data (Fig. 3).  A 1/3 increase in CBZ concentration in August 2015 307 
was not matched by SMX or CLAR.  Indeed the ratio of CLAR to CBZ is unstable indicating changes in 308 
prescription/use is most likely driving the variability in influent concentration for this antibiotic. 309 
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 310 
Figure 3.  Comparison of some antibiotic influent concentrations (ng/l) against carbamazepine (CBZ) over 311 
four years (All data is plotted and the line is the average). 312 
 313 
3.5. Variation in antibiotic removal performance of STPs  314 
The AS pair of Ox and Did were not consistently better than the TF pair of Cho and Ben at 315 
removing antibiotics from the waste stream (Fig 4, Table S6), but performed on average better than 316 
the trickling filter types for two (CLAR and SMX) of the four antibiotics for which sufficient data 317 
were available for a robust comparison.  The mean removals of CLAR and SMX were 79% (SD 18%) 318 
and 40% (SD 22%) respectively for the combined AS plants compared to 36% (SD 26%) and 15% (SD 319 
40%) for the two TFs (Table S6).  For TRIM there was little difference in removals between the ASPs 320 
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(47% (SD 15%) compared to 44% (SD 25%) at the TFs.  For AZO at the ASPs 34% (SD 21%) was 321 
removed compared to 42% (SD 31%) at the TFs.  For the remaining antibiotics LEVO, OXY and TET 322 
only 1-3 valid pairs of influent and effluent concentrations were available for each pair of sewage 323 
works making any comparisons unreliable.  A previous study of the removal of trickling filter plants 324 
reported only 3 to -23% removal for SMX and 40% removal for TRIM (Kasprzyk-Hordern et al., 325 
2009).  The winter period of January 2015 did not produce noticeably worse antibiotic removal 326 
performance than the summer samplings. 327 
Both of the TFs (Ben and Cho) showed considerable variation in antibiotic removal 328 
performance from year to year (Fig.  4). Occasionally, a higher antibiotic concentration was found in 329 
the effluent than influent of those TF plants (TRIM in 2013 in Cho and LEVO in 2012 and SMX in 330 
summer 2015 in Ben).  Analysing 24-hour composite samples reduces the effects of short term 331 
variations compared to grab-samples, but temporal changes in the influent concentrations could 332 
still lead to a certain level of sample mis-match, especially if an unusually high influent 333 
concentration preceded the initiation of sampling or a high load was just about to leave in the 334 
effluent.  It is also possible that higher than expected effluent concentrations were due to the 335 
delayed release of the parent molecule from a conjugate without further significant removal.  Good 336 
performance in removal of one antibiotic in one year did not necessarily translate to good removal 337 
for another antibiotic.  In other words performance was quite unpredictable in all senses for these 338 
TF plants. 339 
In contrast, the AS plant Ox showed remarkable removal consistency for all antibiotics in 340 
each year with the exception of TRIM in summer 2012 and CLAR in winter 2015 (Fig.  4). The highest 341 
removals (84-97%) were for TET and OXY. 342 
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Figure 4.  Differences in removal performance of antibiotics at the different treatment plants over four 344 
years.  Results were calculated from valid duplicate or single paired 24 h composite influent and effluent 345 
samples.  AS: activated sludge process, TF: trickling filter.  346 
 347 
 348 
3.6 Attempting to attribute variation in effluent antibiotic concentration 349 
 350 
 As discussed previously, we may attribute variability in antibiotic effluent concentration to 351 
to changes in wastewater dilution, differences in removal rates (treatment), or to changes in drug 352 
consumption.  Changes in drug consumption rates may be inferred if variability in dilution or STP 353 
removal are insufficient to account for changes in effluent concentration.  Changes in flow within 354 
the STP are assessed by differences in CBZ and could account for some of the variation in every 355 
case.  This was particularly notable as higher flows in January 2015 and lower than usual flows in 356 
August 2015.  Secondly there is the inconsistency in the efficiency of sewage treatment (removal) 357 
most notably in the trickling filter plant Ben (Table 3). Where neither of these two factors are 358 
sufficient to explain the variability in effluent concentrations, a change in the local drug 359 
consumption may be inferred. Thanks to its greater stability of performance and flow at the largest 360 
STP studied (Ox) it is possible to attribute differences in CLAR and LEVO effluent concentrations 361 
there largely to changes in local drug consumption.  For CLAR the influent concentrations during the  362 
winter sampling where higher than expected compared to CBZ (fig. 3) at all four STPs making it 363 
likely that increased prescription in winter played a role here. Similarly, much of the changes in 364 
LEVO at Ben may be attributable to consumption changes. Ben is the smallest STP studied and LEVO 365 
the rarest drug, meaning that if there are only a few people taking it at any one time, so variability 366 
can be introduced just by a single person starting or stopping taking it. However, the influence of 367 
sewage treatment performance for this antibiotic cannot be ruled out because there is insufficient 368 
data to quantify the performance and its variability (fig. 4 and table S6).  369 
 370 
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Table 3.  Analysis of the largest recorded incidences of variation in antibiotic effluent 371 
concentration 372 
 373 
STP Antibiotic Change in 
effluent 
concentration 
Change in 
carbamazepine 
dilution marker 
in effluent 
STP removal 
performance 
Likely attribution of 
variability 
Ox CLAR 16-fold 2-fold 50-95% (2-fold) Largely consumption 
changes 
LEVO 5-fold Consistent 75% Largely consumption 
changes 
Did CLAR 5-fold 4-fold 50-75% (1.5-fold) Instability in flow and 
removal 
SMX 6-fold 0-30% (several-
fold) 
Instability in flow and 
removal 
Cho OXY 7-fold 5-fold Variability 
unknown 
Changes in flow plus 
unknown 
Ben CLAR 5-fold 4-fold 5-25% (5-fold) Instability in flow and 
removal 
SMX 10-fold 20-50% (2.5-fold) Changes in local flow, 
removal and 
consumption 
combined 
LEVO 10-fold 0% Largely a consumption 
issue with a smaller 
influence of changes in 
local flow 
OXY 6-fold Variability 
unknown 
Changes in flow plus 
unknown 
TET 6-fold Variability 
unknown 
Changes in flow plus 
unknown 
 374 
 375 
4. Conclusions 376 
The average influent concentrations of the four sewage plants fell within a maximum factor 377 
of 4 of average predictions based on England-wide prescription data for SMX, TRIM, AZO, OXY, and 378 
LEVO but were 4-11 times less for CLAR whilst TET influent concentrations were 5-16 times greater 379 
than expected.  For the two trickling filter plants, removal rates were very variable both year on 380 
year and without consistency between antibiotics.  The large activated sludge plant (Ox) showed 381 
more consistent removal and better performance than the other plants for CLAR and SMX.  Over 382 
the four years, sewage effluent concentrations varied up to 16-fold CLAR, 10-fold for LEVO and 383 
SMX, 7-fold for oxytetracycline OXY, 6-fold for TET, 4-fold for AZO and 3-fold for TRIM.   384 
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Changes in flow and removal performance within the STPs were clearly playing an important 385 
role in this variability of effluent concentration.  However, these were not sufficient to account for 386 
all the variability in some cases for CLAR and LEVO and here year on year and seasonal changes in 387 
prescriptions and regional prescription preferences are likely to have played a role. 388 
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